leisure time -WSS

leisure time

author：entertainment 2025-09-03 07:37:32 - browse：7264

Two boxes of Ozempic stack on each other, while one lean on the stack tilted — health coverage from STAT — SEBASTIEN BOZON/AFP via Getty Images

Novo Nordisk’s Ozempic cut the risk of death in a trial of patients with type 2 diabetes and chronic kidney disease, suggesting it may offer some added benefits over other classes of drugs approved to treat this population.

Specifically, the diabetes drug cut the risk of cardiovascular-related deaths by 29% and all-cause deaths by 20%. Given the study parameters, this implies that over three years, 39 people would need to be treated to prevent one death from any cause, according to new results presented Friday at a meeting of the European Renal Association and published in the New England Journal of Medicine.

Ozempic also lowered the risk of major heart complications — including cardiovascular-related death, heart attack, or stroke — by 18%, driven primarily by the reduced rate of heart-linked death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Create a giant ice tray with this foil pan hack to keep food cold this summer

Wikipedia

entertainment

WSS

Beware reading your test results before your doctor does

Canadians with cystic fibrosis outlive Americans by a decade

Crowdfunding for unproven stem cell procedures spreads misinformation

Eisai exec who led development of Alzheimer’s drug to retire

Skip the lead apron during X

What affirmative action's end means to a medical student

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

Medical leaders decry Supreme Court decision on affirmative action

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Medicare details structure of new drug price negotiation program

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

DIEP, the 'gold standard' of breast reconstruction, is under threat

Canadians with cystic fibrosis outlive Americans by a decade

After affirmative action ruling, medical educators look to 'holistic review'

Wisconsin governor employs partial veto to fund schools for 4 centuries

explore

Use doctors trained outside the U.S. to ease the physician shortage

Prescription digital therapeutics are key to pharma’s future

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

AstraZeneca lung cancer study comes in below expectations

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Lupron, used to halt puberty in children, may cause lasting health problems

Wikipedia

entertainment

entertainment

knowledge